WiCell Celebrates Grand Opening of New cGMP Testing Laboratory
PRESS RELEASE
January 16, 2025
Madison, WI—WiCell, an organization dedicated to supporting research and the advancement of novel therapies through innovative technologies and services, is pleased to announce the grand opening of its new cGMP laboratory suite dedicated to cell therapy product testing. This state-of-the-art space has been developed to meet the growing global demand for robust cell therapy product characterization and assay development services.
“The new lab space will provide critical support to our clients and allow us to deliver high-quality, regulatory-compliant solutions that drive advancements in cell therapy research and clinical development.” said Seth Taapken, Director of Operations at WiCell.
This new GMP compliant environment strengthens WiCell's commitment to delivering comprehensive testing and characterization services to its diverse clients. Current offerings include cGMP STR profiling, karyotype analysis, and FISH services, which enable researchers to ensure the authenticity, stability, and suitability of cell lines for translational research, therapeutic development, and clinical applications.
Backed by 25 years of experienced and exceptional customer support, WiCell continues to be a trusted lab partner across the life sciences sector. The new cGMP suite will also support the ongoing expansion of WiCell’s service portfolio, facilitating the introduction of new assays and service solutions to meet evolving industry needs.
For more information about WiCell, please visit wicell.org.
About WiCell (wicell.org)
Headquartered in Madison, Wisconsin, WiCell is a supporting organization of the University of Wisconsin–Madison, a world leader in the area of human pluripotent stem cell research. Established in 1999 to advance stem cell technologies, our mission extends beyond providing high-quality stem cell lines and characterization services. We are dedicated to advancing regenerative medicine and cell and gene therapy globally. Through promoting best practices in cell banking and characterization, we aim to support groundbreaking research and clinical applications. Our efforts—rooted in a commitment to quality, innovation, and collaboration—underscore our desire to support the scientific community as your lab partner.
Madison, WI—WiCell, an organization dedicated to supporting research and the advancement of novel therapies through innovative technologies and services, is pleased to announce the grand opening of its new cGMP laboratory suite dedicated to cell therapy product testing. This state-of-the-art space has been developed to meet the growing global demand for robust cell therapy product characterization and assay development services.
“The new lab space will provide critical support to our clients and allow us to deliver high-quality, regulatory-compliant solutions that drive advancements in cell therapy research and clinical development.” said Seth Taapken, Director of Operations at WiCell.
This new GMP compliant environment strengthens WiCell's commitment to delivering comprehensive testing and characterization services to its diverse clients. Current offerings include cGMP STR profiling, karyotype analysis, and FISH services, which enable researchers to ensure the authenticity, stability, and suitability of cell lines for translational research, therapeutic development, and clinical applications.
Backed by 25 years of experienced and exceptional customer support, WiCell continues to be a trusted lab partner across the life sciences sector. The new cGMP suite will also support the ongoing expansion of WiCell’s service portfolio, facilitating the introduction of new assays and service solutions to meet evolving industry needs.
For more information about WiCell, please visit wicell.org.
About WiCell (wicell.org)
Headquartered in Madison, Wisconsin, WiCell is a supporting organization of the University of Wisconsin–Madison, a world leader in the area of human pluripotent stem cell research. Established in 1999 to advance stem cell technologies, our mission extends beyond providing high-quality stem cell lines and characterization services. We are dedicated to advancing regenerative medicine and cell and gene therapy globally. Through promoting best practices in cell banking and characterization, we aim to support groundbreaking research and clinical applications. Our efforts—rooted in a commitment to quality, innovation, and collaboration—underscore our desire to support the scientific community as your lab partner.
